UpDate is a section that will report developments in health policy issues and scheduled conferences of relevance to the field. This issue features a summary of the recent London conference on ...
Phase I/II study of E7050 (golvantinib) in combination with sorafenib in patients (pts) with advanced hepatocellular carcinoma (HCC): Phase I results.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results